The Pediatric Phase I/II Therapeutics program at the Masonic Cancer Center is a source of innovative new treatment regimens for children and young adults with high-risk or relapsed cancers. The Pediatric Phase I/II Therapeutics program is funded through the National Cancer Institute and the Children's Cancer Research Fund to provide new treatments, often referred to as Phase 1 or 2 clinical trials, that complement and integrate with care provided by referring oncologists and other health care professionals.

Acute Lymphoblastic Leukemia Acute Myelogenous Leukemia Brain Tumors Hepatoblastoma Hodgkin Lymphoma Neuroblastoma Non-Hodgkin Lymphoma Osteosarcoma, Ewing's, Other Bone Tumors/Sarcomas Retinoblastoma Wilms' Tumor

The Pediatric Phase I/II Therapeutics Program includes multidisciplinary inpatient and outpatient advanced care facilities, and an integrated pharmacology/pharmacogenetics research program. Learn more about the program.

Learn more about clinical trials, including information on understanding what they are and how to decide to participate in a trial.

View a complete list of cancer clinical trials available for children and adults through the Masonic Cancer Center.